MetaStat Competitors and Similar CompaniesClear all

MetaStat's competitors and similar companies include Immutep.

	MetaStat MetaStat, Inc. develops and commercializes diagnostic tests for risk of cancer metastasis, companion diagnostics and anti-metastatic drugs.	Immutep Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.
Founding Date	Founding Date 2010	Founding Date 2001
Type	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy
Locations	Locations Boston, US HQ	Locations Sydney, AU HQ Sydney, AU The Rocks, AU Orsay, FR Berlin, DE Leipzig, DE
Employees	Employees 6	Employees 2427% decrease
Valuation ($)	Valuation ($) 20.6 k	Valuation ($) 282.4 m
Financial
Revenue (est.)	Revenue (est.) $23.3k (FY, 2018)	Revenue (est.) N/A
Net income	Net income ($3.2m) (FY, 2018)	Net income ($61.4m) (FY, 2025)

For sources of this data, please see the company profile

Sydney, AU

Employees

24↓ 27% decrease

Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.

Financial